Pancreatic volume and endocrine and exocrine functions in patients with diabetes

Pancreas

Volumn 40, Issue 3, 2011, Pages 359-363

  Philippe, Marie France ^a,b   Benabadji, Salim ^a,b   Barbot Trystram, Laurence ^c   Vadrot, Dominique ^a,b   Boitard, Christian ^a,b   Larger, Etienne ^a,b,d  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d INSERM   (France)

Author keywords

diabetes; exocrine pancreas; pancreatic volume

Indexed keywords

C PEPTIDE; CHYMOTRYPSIN; GLUCAGON; INSULIN; ORAL ANTIDIABETIC AGENT; PANCREATIC ELASTASE;

ADULT; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; ENDOCRINE FUNCTION; ENZYME ACTIVITY; FECES; FEMALE; GLUCAGON STIMULATION TEST; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; HOSPITAL PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS; PANCREAS ATROPHY; PANCREAS DISEASE; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS FUNCTION; PANCREAS FUNCTION TEST; PATIENT SELECTION; PRIORITY JOURNAL;

ADULT; AGED; ATROPHY; C-PEPTIDE; CHYMOTRYPSIN; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FECES; FEMALE; GLUCAGON; HUMANS; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; ORGAN SIZE; PANCREAS; PANCREAS, EXOCRINE; PANCREATIC ELASTASE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79954416602     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3182072032     Document Type: Article

References (38)

1. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature. 2010;464(7293):1293-1300.
2. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860-867. (Pubitemid 46024993)
3. Cecil RL. A study of the pathological anatomy of the pancreas in ninety cases of diabetes mellitus. J Exp Med. 1909;11(2):266-290.
4. Volk BW, Wellmann KF. Idiopathic diabetes. In: Volk BW, Wellmann KF, eds. The Diabetic Pancreas. New York: Plenum Press; 1977:230-260.
5. Goda K, Sasaki E, Nagata K, et al. Pancreatic volume in type 1 and type 2 diabetes mellitus. Acta Diabetol. 2001;38(3):145-149. (Pubitemid 34042079)
6. Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat. 2007;20(8):933-942. (Pubitemid 350074312)
7. Gilbeau JP, Poncelet V, Libon E, et al. The density, contour, and thickness of the pancreas in diabetics: CT findings in 57 patients. AJR Am J Roentgenol. 1992;159(3):527-531.
8. Domschke W, Tympner F, Domschke S, et al. Exocrine pancreatic function in juvenile diabetics. Am J Dig Dis. 1975;20(4):309-312.
9. Frier BM, Faber OK, Binder C, et al. The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitus. Diabetologia. 1978;14(5):301-304. (Pubitemid 8321890)
10. Lankisch PG, Manthey G, Otto J, et al. Exocrine pancreatic function in insulin-dependent diabetes mellitus. Digestion. 1982;25(3):211-216. (Pubitemid 13187258)
11. Hardt PD, Krauss A, Bretz L, et al. Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus. Acta Diabetol. 2000;37(3):105-110. (Pubitemid 32157309)
12. Hardt PD, Brendel MD, Kloer HU, et al. Is pancreatic diabetes (type 3C diabetes) underdiagnosed and misdiagnosed? Diabetes Care. 2008;31(suppl 2):S165-S169.
13. Andren-Sandberg A, Hardt PD. Second Giessen International Workshop on Interactions of Exocrine and Endocrine Pancreatic Diseases. Castle of Rauischholzhausen of the Justus-Liebig-University, Giessen (Rauischholzhausen), Germany. March 7-8, 2008. JOP. 2008;9(4):541-575.
14. Keller J, Aghdassi A, Lerch M, et al. Tests of pancreatic function: clinical sigificance in pancreatic and non-pancreatic disorders. Best Pract Res Clin Gastroenterol. 2009;23:425-439.
15. Hahn JU, Kerner W, Maisonneuve P, et al. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus. Pancreas. 2008;36(3):274-278. (Pubitemid 351440932)
16. Hardt PD. Comment on "Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus (Pancreas. 2008;36:274-278)." Pancreas. 2009;38(4):471-472; [author reply 472-473].
17. Geraghty EM, Boone JM, McGahan JP, et al. Normal organ volume assessment from abdominal CT. Abdom Imaging. 2004;29(4):482-490. (Pubitemid 38868788)
18. Stein J, Jung M, Sziegoleit A, et al. Immunoreactive elastase I: clinical evaluation of a new noninvasive test of pancreatic function. Clin Chem. 1996;42(2):222-226. (Pubitemid 26063874)
19. Loser C, Mollgaard A, Folsch UR. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut. 1996;39(4):580-586. (Pubitemid 26376043)
20. DelMar EG, Largman C, Brodrick JW, et al. A sensitive new substrate for chymotrypsin. Anal Biochem. 1979;99(2):316-320. (Pubitemid 10160819)
21. Sobngwi E, Boudou P, Mauvais-Jarvis F, et al. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet. 2003;361(9372):1861-1865. (Pubitemid 36645181)
22. Lohr M, Kloppel G. Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia. 1987;30(10):757-762. (Pubitemid 17163000)
23. Mossner J, Logsdon CD, Williams JA, et al. Insulin, via its own receptor, regulates growth and amylase synthesis in pancreatic acinar AR42J cells. Diabetes. 1985;34(9):891-897. (Pubitemid 15016552)
24. Nyboe Andersen B, Krarup T, Thorsgaard Pedersen NT, et al. B cell function in patients with chronic pancreatitis and its relation to exocrine pancreatic function. Diabetologia. 1982;23(2):86-89. (Pubitemid 12093492)
25. Cavalot F, Bonomo K, Perna P, et al. Pancreatic elastase-1 in stools, a marker of exocrine pancreas function, correlates with both residual beta-cell secretion and metabolic control in type 1 diabetic subjects. Diabetes Care. 2004;27(8):2052-2054. (Pubitemid 38989255)
26. Bilgin M, Balci N, Momtahen A, et al. MRI and MRCP findings of the pancreas in patients with diabetes mellitus. Compared analysis with pancreatic exocrine function determined by fecal elastase 1. J Clin Gastroenterol. 2009;43(2):165-170.
27. Altobelli E, Blasetti A, Verrotti A, et al. Size of the pancreas in children and adolescents with type 1 (insulin-dependent) diabetes. J Clin Ultrasound. 1998;26(8):391-395. (Pubitemid 28440620)
28. Alzaid A, Aideyan O, Nawaz S. The size of the pancreas in diabetes mellitus. Diabetic Med. 1993;10(8):759-763. (Pubitemid 23306900)
29. Silva M, Vezozzo D, Ursich M, et al. Ultrasonographic abnormalities of the pancreas in IDDM and NIDDM patients. Diabetes Care. 1993;16(9):1296-1297. (Pubitemid 23259873)
30. Lankisch PG. Secretion and absorption (methods and functions). Best Pract Res Clin Gastroenterol. 2009;23(3):325-335.
31. Lieb JG 2nd, Draganov PV. Pancreatic function testing: here to stay for the 21st century. World J Gastroenterol. 2008;14(20):3149-3158.
32. Lorini R, Cortona L, Scotta MS, et al. Exocrine pancreatic function in children and adolescents with insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1990;8(3):263-267. (Pubitemid 20111451)
33. Keller J, Aghdassi AA, Lerch MM, et al. Tests of pancreatic exocrine function - clinical significance in pancreatic and non-pancreatic disorders. Best Pract Res Clin Gastroenterol. 2009;23(3):425-439.
34. Bellanne-Chantelot C, Chauveau D, Gautier JF, et al. Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med. 2004;140(7):510-517.
35. Raeder H, Johansson S, Holm PI, et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet. 2006;38(1):54-62. (Pubitemid 43011882)
36. Gianani R, Campbell-Thompson M, Sarkar S, et al. Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia. 2010;53:690-698. Available at: www.jdrfnpod.org.
37. Kauppila LI, Hekali P, Penttila A. Postmortem pancreatic angiography in 45 subjects with non-insulin-dependent diabetes mellitus and 51 controls. Pancreas. 1998;16(1):60-65. (Pubitemid 28034431)
38. Taniguchi T, Okazaki K, Okamoto M, et al. High prevalence of autoantibodies against carbonic anhydrase II and lactoferrin in type 1 diabetes: concept of autoimmune exocrinopathy and endocrinopathy of the pancreas. Pancreas. 2003;27(1):26-30. (Pubitemid 36775975)